Opus Genetics, Inc. (IRD)
4.29
-0.15
(-3.38%)
USD |
NASDAQ |
May 21, 16:00
4.48
+0.19
(+4.43%)
After-Hours: 04:53
Opus Genetics Accounts Payable (Quarterly) : 4.422M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 1.493M |
| Xilio Therapeutics, Inc. | 1.064M |
| ACADIA Pharmaceuticals, Inc. | 12.25M |
| Alnylam Pharmaceuticals, Inc. | 126.63M |
| Amgen, Inc. | 2.935B |